Illustrative image – not actual.SRF has announced its financial results for Q4 and FY ending March 31, 2026, highlighting strong operational performance across key segments.
The Fluorochemicals Business led growth with robust domestic and export demand, particularly in HFCs, alongside steady contributions from Industrial Chemicals and Fluoropolymers. The Specialty Chemicals Business showed sequential improvement over Q3, supported by cost optimisation, efficiency initiatives, and new product launches. The Films and Foil Business delivered healthy results, driven by improved volumes and margins in BOPET and BOPP segments, along with a continued focus on sustainable and value-added offerings.
Strategically, the Board deferred its Rs 490 crore BOPP film project in Indore due to changing market dynamics. SRF has revised its refrigerants project investment from Rs 1,100 crore to about Rs 2,300 crore after acquiring land in Odisha. The expanded plan includes a 20,000 TPA HFO facility, a 30,000 TPA HF plant, and production of value-added HF derivatives, along with supporting infrastructure. The project, based on in-house technology, will be completed in phases by February 2028. The Board has also approved an Rs 88 crore expansion of HFC capacity at Dahej to meet future demand under Kigali Amendment entitlements. The project is nearing commissioning, and capacity will rise to 65,000 TPA after debottlenecking.
